The ACR and SBI took issue with a recent study on the long-term mental anguish caused by false-positives from mammograms.
A recent study reporting the long-term mental anguish in women who obtain false-positives from mammograms should be taken with a grain of salt, say the American College of Radiology (ACR) and the Society of Breast Imaging (SBR). The study findings, published earlier this month in the Annals of Family Medicine, stated that false-positive findings on screening mammography cause long-term harm.
Researchers from Denmark surveyed 454 women who had received abnormal mammography findings following screening over one year. Researchers recruited two women with normal results for each woman who had abnormal results, all from the same day and same clinic. The women completed a validated questionnaire, the Consequences of Screening in Breast Cancer, at baseline, one, six, 18, and 36 months. The questionnaire covers 12 psychosocial outcomes.
The researchers found that six months after the final diagnosis, women who received false-positive findings reported “changes in existential values and inner calmness as great as those reported by women with a diagnosis of breast cancer.” Three years later, these women reported “greater negative psychosocial consequences compared with women who had normal findings in all 12 psychosocial outcomes.”
The study authors concluded that the false-positive findings had long-term implications on women’s psychological health.
The ACR and SBI questioned the methodology of the study, citing irregularities in the analysis, such as if the women with false-positive findings also had a family history of breast cancer, what further testing was done, and where the women completed the survey (at home or at the clinic).
“Anxiety regarding inconclusive test results is real and only natural,” the groups said in a release. “Physicians continue to refine the reporting process to ensure that patients receive results as quickly as possible. Attention to women’s feelings associated with test results is, and should be, a concern for those who provide this care.”
The organizations emphasized that the benefits of breast cancer screening outweigh potential harm.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.